Chemical | 26 February 2021
Arkema’s Q4 EBITDA remains stable
The divestment of PMMA is expected to close in mid-year.
The divestment of PMMA is expected to close in mid-year.
Building upon the momentum gained by pharma sector during the pandemic, Indian Pharmaceutical Alliance is leaving no stone unturned to create a faster road to recovery.
The resilient attitude of Indian pharmaceutical companies coupled with quick innovative solutions has ensured consistency in supply chains amid unprecedented challenges
Total incremental sales of Rs.2,94,000 crore and total incremental exports of Rs.1,96,000 crore are estimated during six years from 2022-23 to 2027-28.
IWAI inks MoU with MOL (Asia Oceania)
Bpifrance Participations will increase its shareholding in the Target to a stake of 14.07-20%.
The Govt. launched the PLI scheme for bulk drugs with a financial outlay of Rs 6,940 crores across 53 APIs over 6 years.
Company intends to use results from the Baytown trial to scale-up advanced recycling capabilities at other global facilities, targeting a circular solution for converting difficult-to-recycle plastic waste into feedstock for virgin-quality plastic
The expansion project, budgeted at $61 million, will be rolled out in 2021 and should be concluded in the fourth quarter of 2022
Net sales for the full year 2020 were down 10% organically.
Creation of information and communication facilities to help harness the full potential of development in the region
While top industry leaders are optimistic about the growth, they expect the special incentives and regulatory streamlining from the government’s side
The chemical industry’s output is expected to grow by 3% in 2021 and 2% in 2022.
The proposed facility has a design capacity of 250,000 tons of MMA annually.
The SEAL (Sustainability, Environmental Achievement & Leadership) Awards honored the companies for their teamwork to create the new packaging structure.
DURABIO’s addition to the USDA’s list of biobased products will provide recognition both in North America and internationally of the sustainability benefits this product can provide.
MCC’s MMA operations have 11 monomer plants and 6 polymer (acrylic resin) plants in growth markets around the world.
ranules now has a total of 38 ANDA approvals from US FDA.
.jpg)
The company will be holding 26% of the share capital in each of the solar power generating companies.
Subscribe To Our Newsletter & Stay Updated
